Basics Amneal Pharmaceuticals, Inc. IPO Date: January 1, 1900 Sector: Healthcare Industry: Biotech Market Cap: $2.31B Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 2.54% Avg Daily Range (30 D): $0.17 | 2.11% Avg Daily Range (90 D): $0.13 | 1.66% Institutional Daily Volume Avg Daily Volume: .37M Avg Daily Volume (30 D): 1.53M Avg Daily Volume (90 D): 1.24M Trade Size Avg Trade Size (Sh.): 155 Avg Trade Size (Sh.) (30 D): 90 Avg Trade Size (Sh.) (90 D): 90 Institutional Trades Total Inst.Trades: 1,587 Avg Inst. Trade: $1.52M Avg Inst. Trade (30 D): $2.45M Avg Inst. Trade (90 D): $1.8M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.62M Avg Closing Trade (30 D): $2.75M Avg Closing Trade (90 D): $1.95M Avg Closing Volume: 195.51K         News Apr 22, 2025 @ 5:00 PM Parkinson’s Disease Therapeutic Domain Proj... Source: Delveinsight Mar 7, 2025 @ 3:49 PM Polycystic Ovarian Syndrome Treatment Market Set f... Source: Transparency Market Research Inc. Nov 25, 2024 @ 4:00 PM Glioblastoma Multiforme Treatment Market Size to R... Source: Precedence Research Sep 9, 2024 @ 10:00 AM Opioid Overdose Treatment Market is Projected to R... Source: Fact.Mr Sep 6, 2024 @ 5:46 PM JP Morgan Shows Most Interest In Teva, Organon As ... Source: Vandana Singh Financials   TTM Q4 2024 FY 2024 Basic EPS $-.38 $-.1 $-.38 Diluted EPS $-.38 $-.1 $-.38 Revenue $ 2.79B $ 730.52M $ 2.79B Gross Profit $ 1.02B $ 262.87M $ 1.02B Net Income / Loss $ -73.88M $ -20.74M $ -73.88M Operating Income / Loss $ 249.33M $ 75.79M $ 249.33M Cost of Revenue $ 1.77B $ 467.65M $ 1.77B Net Cash Flow $ 19.31M $ 40.08M $ 19.31M PE Ratio     Splits Aug 26, 2013:   25:1